"Medicare Part D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stand-alone drug plan offered by insurers and other private companies to beneficiaries that receive their Medicare Part A and/or B benefits through the Original Medicare Plan. It includes Medicare Private Fee-for-Service Plans that do not offer prescription drug coverage and Medicare Cost Plans offering Medicare prescription drug coverage. The plan was enacted as the Medicare Prescription Drug, Improvement and Modernization Act of 2003 with coverage beginning January 1, 2006.
| Descriptor ID |
D054524
|
| MeSH Number(s) |
N03.219.521.576.343.575.500 N03.219.521.576.343.840.938 N03.706.615.752
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medicare Part D".
Below are MeSH descriptors whose meaning is more specific than "Medicare Part D".
This graph shows the total number of publications written about "Medicare Part D" by people in this website by year, and whether "Medicare Part D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 2 | 3 |
| 2012 | 1 | 0 | 1 |
| 2018 | 0 | 3 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medicare Part D" by people in Profiles.
-
Barbarite E, Occhiogrosso J, McCarty JC, Lee LN, Hadlock TA, Shaye DA, Gadkaree SK. Opioid Prescribing Patterns Among Facial Plastic and Reconstructive Surgeons in the Medicare Population. Facial Plast Surg Aesthet Med. 2021 12; 23(6):401-404.
-
Arianpour K, Svider PF, Guys N, Shenouda K, Folbe E, Hsueh WD, Eloy JA, Folbe AJ. Incorporation of antibiotics and systemic steroids by sinus surgeons: is there widespread consensus? Int Forum Allergy Rhinol. 2018 09; 8(9):1034-1040.
-
Arianpour K, Nguyen B, Yuhan B, Svider PF, Eloy JA, Folbe AJ. Opioid Prescription Among Sinus Surgeons. Am J Rhinol Allergy. 2018 Jul; 32(4):323-329.
-
Svider PF, Arianpour K, Guo E, Folbe E, Zuliani G, Lin H, Eloy JA, Folbe AJ. Opioid prescribing patterns among otolaryngologists: Crucial insights among the medicare population. Laryngoscope. 2018 07; 128(7):1576-1581.
-
Stefanacci RG. 'B' isn't always for biologics. Manag Care. 2012 Feb; 21(2):50-4.
-
Stefanacci RG. The costs of Alzheimer's disease and the value of effective therapies. Am J Manag Care. 2011 Nov; 17 Suppl 13:S356-62.
-
Lam BL, Zheng DD, Davila EP, Arheart KL, Ocasio MA, McCollister KE, Caban-Martinez AJ, Lee DJ. Trends in glaucoma medication expenditure: Medical Expenditure Panel Survey 2001-2006. Arch Ophthalmol. 2011 Oct; 129(10):1345-50.
-
Schlosberg C, Stefanacci R. Part D model guidelines updated far too infrequently. Manag Care. 2011 Mar; 20(3):38-40.
-
Golden AG, Fass J, Tewary S, Stefanacci RG, Roos BA. Cost consideration by Medicare Part D plans may promote the use of potentially inappropriate medications. J Am Geriatr Soc. 2010 May; 58(5):979-81.
-
Stefanacci RG. Balancing the policy with appropriate patient care. Manag Care. 2008 Jul; 17(7 Suppl 6):16-9.